HCG announced Q4 and FY26 results with 15% YoY revenue growth to ₹25,454 million for the full year.
Adjusted EBITDA grew 19% to ₹4,711 million with margins expanding to 18.5% for FY26.
The company completed a ₹4,250 million rights issue to strengthen its financial foundation for future growth.
HCG operates 25 cancer care hospitals across India and Africa, focusing on integrated oncology services.